Size: 40 µg
Type: Synthetic peptide
Form: Lyophilized Powder
Applications: wb, ihc
For research purposes only. not for human use
Properties
Sequence
- Peptide (C)GKNIYRKQSGSPTLD corresponding to amino acid residues 691 - 705 of mouse SLC6A15 (Accession Q8BG16).
Accession (Uniprot) Number Q8BG16
Peptide Confirmation Confirmed by amino acid analysis and mass spectrometry.
Purity >70%
Storage Before Reconstitution Lyophilized powder can be stored intact at room temperature for two weeks. For longer periods, it should be stored at -20°C.
Reconstitution 100 µl double distilled water (DDW).
Concentration After Reconstitution 0.4 mg/ml.
Storage After Reconstitution -20°C.
Antigen Preadsorption Control 1 µg peptide per 1 µg antibody.
Standard Quality Control Of Each Lot Western blot analysis.
Applications
Demonstration of Pre-adsorption control
- Western blot analysis (1:200-1:600).
Western blot analysis of mouse brain membranes (lanes 1 and 3) and rat brain membranes (lanes 2 and 4):1-2. Anti-SLC6A15 Antibody (#AGT-016), (1:200). 3-4. Anti-SLC6A15 Antibody, preincubated with SLC6A15 Blocking Peptide (BLP-GT016).
Western blot analysis of human SH-SY5Y neuroblastoma cell line lysate:1. Anti-SLC6A15 Antibody (#AGT-016), (1:200). 2. Anti-SLC6A15 Antibody, preincubated with SLC6A15 Blocking Peptide (BLP-GT016).
Western blot analysis of mouse brain membranes (lanes 1 and 3) and rat brain membranes (lanes 2 and 4):1-2. Anti-SLC6A15 Antibody (#AGT-016), (1:200). 3-4. Anti-SLC6A15 Antibody, preincubated with SLC6A15 Blocking Peptide (BLP-GT016).
Western blot analysis of human SH-SY5Y neuroblastoma cell line lysate:1. Anti-SLC6A15 Antibody (#AGT-016), (1:200). 2. Anti-SLC6A15 Antibody, preincubated with SLC6A15 Blocking Peptide (BLP-GT016).
Last update: 02/01/2024
